Figure 11

Drug release study of Fe3O4@SiO2@TAD-G3/Drug in simulated gastric fluid (SGF, pH 1.5) and simulated intestinal fluid (SIF, pH 6.8) for (a) Zidovudine, and (b) Favipiravir as model drugs.

Drug release study of Fe3O4@SiO2@TAD-G3/Drug in simulated gastric fluid (SGF, pH 1.5) and simulated intestinal fluid (SIF, pH 6.8) for (a) Zidovudine, and (b) Favipiravir as model drugs.